XML 16 R5.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in-Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Sep. 30, 2024   24,392        
Beginning balance at Sep. 30, 2024 $ (962,679) $ 244 $ 1,366,572 $ (6,138,736) $ 3,900,870 $ (91,629)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation 82,358   82,358      
Issuance of treasury stock under employee stock plans (in shares)   151        
Issuance of treasury stock under employee stock plans (182,468) $ 2 (197,146) 14,676    
Repurchases of common stock (in shares)   (191)        
Repurchases of common stock (366,759) $ (2)   (366,757)    
Net income 315,143       315,143  
Foreign currency translation adjustments (9,647)         (9,647)
Ending balance (in shares) at Mar. 31, 2025   24,352        
Ending balance at Mar. 31, 2025 (1,124,052) $ 244 1,251,784 (6,490,817) 4,216,013 (101,276)
Beginning balance (in shares) at Dec. 31, 2024   24,443        
Beginning balance at Dec. 31, 2024 (1,138,164) $ 244 1,201,828 (6,285,951) 4,053,398 (107,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation 41,704   41,704      
Issuance of treasury stock under employee stock plans (in shares)   21        
Issuance of treasury stock under employee stock plans 10,396 $ 1 8,252 2,143    
Repurchases of common stock (in shares)   (112)        
Repurchases of common stock (207,010) $ (1)   (207,009)    
Net income 162,615       162,615  
Foreign currency translation adjustments 6,407         6,407
Ending balance (in shares) at Mar. 31, 2025   24,352        
Ending balance at Mar. 31, 2025 (1,124,052) $ 244 1,251,784 (6,490,817) 4,216,013 (101,276)
Beginning balance (in shares) at Sep. 30, 2025   23,764        
Beginning balance at Sep. 30, 2025 (1,745,784) $ 238 1,331,120 (7,537,908) 4,552,816 (92,050)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation 89,579   89,579      
Issuance of treasury stock under employee stock plans (in shares)   110        
Issuance of treasury stock under employee stock plans (90,832) $ 1 (103,955) 13,122    
Repurchases of common stock (in shares)   (579)        
Repurchases of common stock (773,949) $ (6)   (773,943)    
Net income 422,831       422,831  
Foreign currency translation adjustments (3,495)         (3,495)
Ending balance (in shares) at Mar. 31, 2026   23,295        
Ending balance at Mar. 31, 2026 (2,101,650) $ 233 1,316,744 (8,298,729) 4,975,647 (95,545)
Beginning balance (in shares) at Dec. 31, 2025   23,763        
Beginning balance at Dec. 31, 2025 (1,808,134) $ 238 1,262,018 (7,689,462) 4,711,189 (92,117)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation 45,310   45,310      
Issuance of treasury stock under employee stock plans (in shares)   16        
Issuance of treasury stock under employee stock plans 11,415   9,416 1,999    
Repurchases of common stock (in shares)   (484)        
Repurchases of common stock (611,271) $ (5)   (611,266)    
Net income 264,458       264,458  
Foreign currency translation adjustments (3,428)         (3,428)
Ending balance (in shares) at Mar. 31, 2026   23,295        
Ending balance at Mar. 31, 2026 $ (2,101,650) $ 233 $ 1,316,744 $ (8,298,729) $ 4,975,647 $ (95,545)